Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,860 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature

NCT00198380

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +10 more
Locations
  • CHU Besancon - Pneumologie Besançon, France
  • APHP - CHU Avicenne - Oncologie Medicale Bobigny, France
  • Centre F. Baclesse Caen, France
  • CHU - Pneumologie Caen, France
View Trial Details
Completed

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

NCT02620280

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Brustgesundheitzentrum Tirol, Univ. Frauenklinik Innsbruck Innsbruck, Austria
  • Universitätsklinik für Innere Medizin III, mit Hämatologie, internistischer Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum Salzburg, Austria
  • Klinikum Augsburg International Patient Service Augsburg, Germany
  • Frauenarzt-Zentrum-Zehlendorf Berlin, Germany
View all 41 locations
View Trial Details
Completed

A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer

NCT04069026

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, +14 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Greenville Health System Greenville, South Carolina, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics | START San Antonio San Antonio, Texas, United States
View all 17 locations
View Trial Details
Completed

A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)

NCT03861793

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +18 more
Locations
  • Mural Oncology Investigational Site Los Angeles, California, United States
  • Mural Oncology Investigational Site Los Angeles, California, United States
  • Mural Oncology Investigational Site Washington D.C., District of Columbia, United States
  • Mural Oncology Investigational Site Atlanta, Georgia, United States
View all 48 locations
View Trial Details

Related conditions